[HTML][HTML] Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses

Y Chen, X Zhao, H Zhou, H Zhu, S Jiang… - Nature Reviews …, 2023 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged
pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus …

[HTML][HTML] Features, evaluation, and treatment of coronavirus (COVID-19)

M Cascella, M Rajnik, A Aleem, SC Dulebohn… - Statpearls …, 2023 - ncbi.nlm.nih.gov
Objectives: Screen individuals based on exposure and symptom criteria to identify potential
COVID-19 cases. Identify the clinical features and radiological findings expected in patients …

[HTML][HTML] Exploring the interrelationship between covid-19 phobia, work–family conflict, family–work conflict, and life satisfaction among school administrators for …

T Karakose, R Yirci, S Papadakis - Sustainability, 2021 - mdpi.com
This study aims to investigate the relationships between the COVID-19 phobia experienced
by school administrators and their work–family conflict, family–work conflict, and life …

Proportion of asymptomatic infection and nonsevere disease caused by SARS‐CoV‐2 Omicron variant: a systematic review and analysis

W Yu, Y Guo, S Zhang, Y Kong, Z Shen… - Journal of Medical …, 2022 - Wiley Online Library
SARS‐CoV‐2 Omicron variant seemed to cause milder disease compared to previous
predominated variants. We aimed to conduct a meta‐analysis to assess the pooled …

Molecular evolution of SARS‐CoV‐2 from December 2019 to August 2022

JM Wolf, LM Wolf, GL Bello, JG Maccari… - Journal of medical …, 2023 - Wiley Online Library
Severe acute respiratorysyndrome coronavirus‐2 (SARS‐CoV‐2) pandemic spread rapidly
and this scenario is concerning worldwide, presenting more than 590 million coronavirus …

[HTML][HTML] Emergence of SARS-CoV-2 variants in the world: how could this happen?

A Parra-Lucares, P Segura, V Rojas, C Pumarino… - Life, 2022 - mdpi.com
The COVID-19 pandemic has had a significant global impact, with more than 280,000,000
people infected and 5,400,000 deaths. The use of personal protective equipment and the …

Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: a systematic review

F Nabizadeh, M Noori, S Rahmani… - Journal of Clinical …, 2023 - Elsevier
Background Although global vaccination against COVID-19 infection has its excellence,
potential side effects are yet of concern. Several lines of evidence have proposed ADEM …

Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms

Y Xiong, GH Zhu, YN Zhang, Q Hu, HN Wang… - International Journal of …, 2021 - Elsevier
Abstract Coronavirus 3C-like protease (3CL pro) is a crucial target for treating coronavirus
diseases including COVID-19. Our preliminary screening showed that Ampelopsis …

[HTML][HTML] Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications

L Chen, J Qu, FS Kalyani, Q Zhang, L Fan… - Cellular and Molecular …, 2022 - Springer
As a result of cross-species transmission in December 2019, the coronavirus disease 2019
(COVID-19) became a serious endangerment to human health and the causal agent of a …

[HTML][HTML] Repositioning Ivermectin for COVID-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication

ZY Low, AJW Yip, SK Lal - Biochimica et Biophysica Acta (BBA)-Molecular …, 2022 - Elsevier
Ivermectin (IVM) is an FDA approved macrocyclic lactone compound traditionally used to
treat parasitic infestations and has shown to have antiviral potential from previous in-vitro …